Neurobo Pharmaceuticals Inc (NASDAQ:NRBO)
| 0.5797 Delayed Data As of May 26 |  +0.0109 / +1.92%Today’s Change | 0.55 Today|||52-Week Range 63.85 | -19.21% Year-to-Date |
Latest NRBO News | Press Releases
No recent news for Neurobo Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.57 |
| Today’s open | 0.57 |
| Day’s range | 0.56 - 0.58 |
| Volume | 1,020 |
| Average volume (3 months) | 659,850 |
| Market cap | $15.7M |
Data as of 3:57pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +72.61% |
| Earnings growth (this year) | +87.11% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.67 |
Competitors
Data as of 3:58pm ET, 05/26/2023
Financials
| Last reporting date | May 29, 2023 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
